San Diego, CA, United States of America

Srinath Cidambi Sampath

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Srinath Cidambi Sampath. Retrieved from https://idiyas.com/inventor/srinath-cidambi-sampath

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Srinath Cidambi Sampath

Introduction

Srinath Cidambi Sampath is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of therapeutic proteins, particularly through his innovative work at Novartis AG. His research focuses on novel compositions and methods that have the potential to impact medical treatments.

Latest Patents

Srinath holds a patent for "Compositions, methods, and therapeutic uses related to fusogenic protein minion." This invention provides novel compositions, methods, and therapeutic uses related to the fusogenic protein MINION, which stands for microprotein inducer of fusion. His work in this area showcases his commitment to advancing therapeutic technologies.

Career Highlights

Srinath's career at Novartis AG has been marked by his dedication to research and development in the pharmaceutical industry. His innovative approach has led to the creation of valuable therapeutic solutions that address critical health challenges.

Collaborations

Srinath has collaborated with notable colleagues, including Christian Schmedt and Srihari Cidambi Sampath. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Srinath Cidambi Sampath is a prominent figure in the field of therapeutic innovations, with a focus on fusogenic proteins. His contributions at Novartis AG and his patent for MINION highlight his role in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…